2014
DOI: 10.1016/s1665-2681(19)30845-2
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology of HCC in Brazil: Incidence and risk factors in a ten-year cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
34
1
11

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 61 publications
(48 citation statements)
references
References 21 publications
2
34
1
11
Order By: Relevance
“…We reviewed 232 articles which potentially met the inclusion criteria in their entirety. After full article review, 22 articles fulfilled our criteria for inclusion in the systematic review and meta‐analysis (Figure ) …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…We reviewed 232 articles which potentially met the inclusion criteria in their entirety. After full article review, 22 articles fulfilled our criteria for inclusion in the systematic review and meta‐analysis (Figure ) …”
Section: Resultsmentioning
confidence: 99%
“…Although some prospective studies clearly described that no reminders were offered to patients, and some study protocols did not mention any measures to promote HCC surveillance completion, a number of factors may still contribute to higher adherence in a surveillance prospective study. First, patients selected and/or agreed to participate in a prospective study may be higher risk patients and/or more motivated patients, both of which will improve adherence .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this study, 75 of 453 (16.6%) patients developed HCC over 10 years - a higher incidence than the 8.1% observed in a cohort followed-up in the Southeast of Brazil[26]. Data from other countries also reveal higher incidences in various populations, such as 17.5% in the United States[27] and 27% in an Italian cohort[28].…”
Section: Discussionmentioning
confidence: 72%
“…The majority of HCC cases occur in cirrhotic liver, and the primary risk factors are chronic hepatitis B virus or chronic hepatitis C virus (HCV) infection, which account for almost all HCC cases (2). The incidence of HCC varies between different geographical areas; however, it is increasing globally, particularly in Asia, with 6–11 per 100,000 people with the disease (3,4). A study of HCC epidemiology in Germany indicated that, despite the availability of various advanced chemotherapies and radiotherapies, including chemoembolization with drug-eluting beads, sorafenib and selective internal radiotherapy, the overall survival rate has not improved (5).…”
Section: Introductionmentioning
confidence: 99%